As of 2023, private non-profit expenditure on R&D in medical and health sciences in Canada was approximately 48.5 million USD PPP. From 2024 to 2028, a continuous decline is forecasted, with expenditures decreasing from 47.69 million USD PPP to 43.89 million USD PPP. The year-on-year reductions indicate a downward trend, averaging at a compound annual growth rate (CAGR) of about -2% over these five years.
Future trends to watch include potential shifts in funding priorities due to emerging health challenges, government policies influencing non-profit funding, and technological advancements that might redirect R&D focus and expenditure levels.
